Jaguar Health’s (JAGX) Napo Pharmaceuticals announced that the data from the recently conducted analysis of the prespecified subgroup of adult patients with breast cancer from the Phase 3 OnTarget ...
DUBLIN--(BUSINESS WIRE)--The "Development of Combination Products: Critical Interactions Training Course (February 9-10, 2026)" training has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback